Differentiation of cardiomyocytes from human embryonic stem cells is accompanied by changes in the extracellular matrix production of versican and hyaluronan

Journal of Cellular Biochemistry

Volumn 111, Issue 3, 2010, Pages 585-596

  Chan, Christina K ^a   Rolle, Marsha W ^a   Potter Perigo, Susan ^a   Braun, Kathleen R ^a   Van Biber, Benjamin P ^b   Laflamme, Michael A ^b   Murry, Charles E ^b   Wight, Thomas N ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cardiomyocyte; Differentiation; Glycosylation; Hyaluronan; Stem Cells; Versican

Indexed keywords

HEPARAN SULFATE; HYALURONIC ACID; ISOPROTEIN; MESSENGER RNA; OLIGOSACCHARIDE; VERSICAN;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; EMBRYO; EMBRYO CELL; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; MUSCLE FIBER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SMOOTH MUSCLE FIBER; SYNTHESIS;

CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; EMBRYONIC STEM CELLS; EXTRACELLULAR MATRIX; HUMANS; HYALURONIC ACID; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; MYOCYTES, CARDIAC; VERSICANS;

EID: 78651280827     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22744     Document Type: Article

References (63)

1. Apte SS. 2009. A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: Functions and mechanisms. J Biol Chem 284:31493-31497.
2. Badcock G, Pigott C, Goepel J, Andrews PW. 1999. The human embryonal carcinoma marker antigen TRA-1-6 is a sialylated keratan sulfate proteoglycan. Cancer Res 59:4715-4719.
3. Bode-Lesniewska B, Dours-Zimmermann MT, Odermatt BF, Briner J, Heitz PU, Zimmermann DR. 1996. Distribution of the large aggregating proteoglycan versican in adult human tissues. J Histochem Cytochem 44:303-312.
4. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, Calabro A, Jr., Kubalak S, Klewer SE, McDonald JA. 2000. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan- mediated transformation of epithelium to mesenchyme. J Clin Invest 106:349-360.
5. Czipri M, Otto JM, Cs-Szabo G, Kamath RV, Vermes C, Firneisz G, Kolman KJ, Watanabe H, Li Y, Roughley PJ, Yamada Y, Olsen BR, Glant TT. 2003. Genetic rescue of chondrodysplasia and the perinatal lethal effect of cartilage link protein deficiency. J Biol Chem 278:39214-39223.
6. Engler AJ, Sen S, Sweeney HL, Discher DE. 2006. Matrix elasticity directs stem cell lineage specification. Cell 126:677-689.
7. Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak- Novakovic G. 2007. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA 104:11298-11303. (Pubitemid 47175135)
8. Hascall VC, Calabro A, Midura RJ, Yanagishita M. 1994. Isolation and characterization of proteoglycans. Methods Enzymol 230:390-417.
9. Haylock DN, Nilsson SK. 2005. Stem cell regulation by the hematopoietic stem cell niche. Cell Cycle 4:1353-1355.
10. Henderson DJ, Copp AJ. 1998. Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse heart. Circ Res 83:523-532.
11. Ito Y, Seno S, Nakamura H, Fukui A, Asashima M. 2008. XHAPLN3 plays a key role in cardiogenesis by maintaining the hyaluronan matrix around heart anlage. Dev Biol 319:34-45.
12. Kannagi R, Cochran NA, Ishigami F, Hakomori S, Andrews PW, Knowles BB, Solter D. 1983. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 2:2355-2361.
13. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L. 2001. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108:407-414.
14. Kenagy RD, Plaas AH, Wight TN. 2006. Versican degradation and vascular disease. Trends Cardiovasc Med 16:209-215.
15. Kern CB, Twal WO, Mjaatvedt CH, Fairey SE, Toole BP, Iruela-Arispe ML, Argraves WS. 2006. Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev Dyn 235:2238-2247.
16. Kern CB, Norris RA, Thompson RP, Argraves WS, Fairey SE, Reyes L, Hoffman S, Markwald RR, Mjaatvedt CH. 2007. Versican proteolysis mediates myocardial regression during outflow tract development. Dev Dyn 236:671-683.
17. Kinsella MG, Wight TN. 1988. Structural characterization of heparan sulfate proteoglycan subclasses isolated from bovine aortic endothelial cell cultures. Biochemistry 27:2136-2144.
18. Kruithof BP, Krawitz SA, Gaussin V. 2007. Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. Dev Biol 302:208-217.
19. Kurpinski K, Chu J, Hashi C, Li S. 2006. Anisotropic mechanosensing by mesenchymal stem cells. Proc Natl Acad Sci USA 103:16095-16100.
20. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
21. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE. 2007. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25:1015-1024.
22. LeBaron RG, Zimmermann DR, Ruoslahti E. 1992. Hyaluronate binding properties of versican. J Biol Chem 267:10003-10010.
23. Lemire JM, Merrilees MJ, Braun KR, Wight TN. 2002. Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J Cell Physiol 190:38-45.
24. Lemire JM, Chan CK, Bressler S, Miller J, LeBaron RG, Wight TN. 2007. Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells. J Cell Biochem 101:753-766.
25. Li L, Xie T. 2005. Stem cell niche: Structure and function. Annu Rev Cell Dev Biol 21:605-631.
26. Matsumoto K, Shionyu M, Go M, Shimizu K, Shinomura T, Kimata K, Watanabe H. 2003. Distinct interaction of versican/PG-M with hyaluronan and link protein. J Biol Chem 278:41205-41212.
27. McDevitt TC, Laflamme MA, Murry CE. 2005. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3- kinase/Akt signaling pathway. J Mol Cell Cardiol 39:865-873.
28. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR. 1998. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol 202:56-66.
29. Moore KA, Lemischka IR. 2006. Stem cells and their niches. Science 311: 1880-1885.
30. Morton SU, Scherz PJ, Cordes KR, Ivey KN, Stainier DY, Srivastava D. 2008. microRNA-138 modulates cardiac patterning during embryonic development. Proc Natl Acad Sci USA 105:17830-17835.
31. Muramatsu T, Muramatsu H. 2004. Carbohydrate antigens expressed on stem cells and early embryonic cells. Glycoconj J 21:41-45.
32. Olin KL, Potter-Perigo S, Barrett PH, Wight TN, Chait A. 1999. Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells. J Biol Chem 274:34629-34636.
33. Qu X, Jia H, Garrity DM, Tompkins K, Batts L, Appel B, Zhong TP, Baldwin HS. 2008. Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish. Dev Biol 317:486-496.
34. Rahmani M, Read JT, Carthy JM, McDonald PC, Wong BW, Esfandiarei M, Si X, Luo Z, Luo H, Rennie PS, McManus BM. 2005. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells. J Biol Chem 280:13019-13028.
35. Rahmani M, Wong BW, Ang L, Cheung CC, Carthy JM, Walinski H, McManus BM. 2006. Versican: Signaling to transcriptional control pathways. Can J Physiol Pharmacol 84:77-92.
36. 442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 276:13372-13378.
37. Sasaki N, Okishio K, Ui-Tei K, Saigo K, Kinoshita-Toyoda A, Toyoda H, Nishimura T, Suda Y, Hayasaka M, Hanaoka K, Hitoshi S, Ikenaka K, Nishihara S. 2008. Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. J Biol Chem 283:3594-3606.
38. Satomaa T, Heiskanen A, Mikkola M, Olsson C, Blomqvist M, Tiittanen M, Jaatinen T, Aitio O, Olonen A, Helin J, Hiltunen J, Natunen J, Tuuri T, Otonkoski T, Saarinen J, Laine J. 2009. The N-glycome of human embryonic stem cells. BMC Cell Biol 10:42.
39. Scadden DT. 2006. The stem-cell niche as an entity of action. Nature 441:1075-1079.
40. Schönherr E, Järveläinen HT, Sandell LJ, Wight TN. 1991. Effects of plateletderived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 266:17640-17647.
41. Schönherr E, Järveläinen HT, Kinsella MG, Sandell LJ, Wight TN. 1993. Platelet-derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler Thromb 13:1026-1036.
42. Shukla S, Nair R, Rolle MW, Braun KR, Chan CK, Johnson PY, Wight TN, McDevitt TC. 2010. Synthesis and organization of hyaluronan and versican by embryonic stem cells undergoing embryoid body differentiation. J Histochem Cytochem 58:345-358.
43. Snir M, Kehat I, Gepstein A, Coleman R, Itskovitz-Eldor J, Livne E, Gepstein L. 2003. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 285:H2355-H2363.
44. Stern R. 2004. Hyaluronan catabolism: A new metabolic pathway. Eur J Cell Biol 83:317-325.
45. Stern R, Asari AA, Sugahara KN. 2006. Hyaluronan fragments: An information- rich system. Eur J Cell Biol 85:699-715.
46. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
47. Toole BP. 2001. Hyaluronan in morphogenesis. Semin Cell Dev Biol 12: 79-87.
48. Ueno S, Weidinger G, Osugi T, Kohn AD, Golob JL, Pabon L, Reinecke H, Moon RT, Murry CE. 2007. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci USA 104:9685-9690.
49. 44 positive macrophages take up hyaluronan during lung development. Dev Biol 155:324-336.
50. Wasteson Å , Uthne K, Westermark B. 1973. A novel assay for the biosynthesis of sulfated polysaccharide and its application to studies on the effects of somatomedin on cultured cells. Biochem J 136:1069-1074.
51. Watanabe H, Yamada Y. 1999. Mice lacking link protein develop dwarfism and craniofacial abnormalities. Nat Genet 21:225-229.
52. Wight TN. 2002. Versican: A versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14:617-623.
53. Wight TN, HeinegÅrd DK, Hascall VC. 1991. Proteoglycans: Structure and function. In: Hay ED, editor. Cell biology of extracellular matrix. New York: Plenum Press. pp 45-78.
54. Wilkinson TS, Potter-Perigo S, Tsoi C, Altman LC, Wight TN. 2004. Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. Am J Respir Cell Mol Biol 31:92-99.
55. Wilkinson TS, Bressler SL, Evanko SP, Braun KR, Wight TN. 2006. Overexpression of hyaluronan synthases alters vascular smooth muscle cell phenotype and promotes monocyte adhesion. J Cell Physiol 206:378-385.
56. Wirrig EE, Snarr BS, Chintalapudi MR, O'Neal JL, Phelps AL, Barth JL, Fresco VM, Kern CB, Mjaatvedt CH, Toole BP, Hoffman S, Trusk TC, Argraves WS, Wessels A. 2007. Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development. Dev Biol 310:291-303.
57. Wu YJ, La Pierre DP, Wu J, Yee AJ, Yang BB. 2005. The interaction of versican with its binding partners. Cell Res 15:483-494.
58. Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK. 2001. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19:971-974. (Pubitemid 32947578)
59. Xu C, Police S, Rao N, Carpenter MK. 2002. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91:501-508.
60. Yamamura H, Zhang M, Markwald RR, Mjaatvedt CH. 1997. A heart segmental defect in the anterior-posterior axis of a transgenic mutant mouse. Dev Biol 186:58-72.
61. Zanin MK, Bundy J, Ernst H, Wessels A, Conway SJ, Hoffman S. 1999. Distinct spatial and temporal distributions of aggrecan and versican in the embryonic chick heart. Anat Rec 256:366-380.
62. Zimmermann D. 2000. Versican. In: Iozzo R, editor. Proteoglycans: Structure, biology and molecular interactions. New York: Marcel Dekker, Inc. pp 327-341.
63. Zimmermann DR, Dours-Zimmermann MT, Schubert M, Bruckner-Tuderman L. 1994. Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network in the dermis. J Cell Biol 124:817-825.